Tauns Laboratories (TSE:197A) Long-Term Capital Lease Obligation : 円0 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Tauns Laboratories Long-Term Capital Lease Obligation?

Tauns Laboratories's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was 円0 Mil.

Tauns Laboratories Long-Term Capital Lease Obligation Historical Data

The historical data trend for Tauns Laboratories's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tauns Laboratories Long-Term Capital Lease Obligation Chart

Tauns Laboratories Annual Data

Trend

Jun22

Jun23

Jun24

Long-Term Capital Lease Obligation

Tauns Laboratories Quarterly Data
	Jun22	Jun23	Mar24	Jun24	Dec24
Long-Term Capital Lease Obligation	-	-	-	-	-

Tauns Laboratories (TSE:197A) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Tauns Laboratories Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Tauns Laboratories's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Tauns Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tauns Laboratories Inc (TSE:197A) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325

Website

https://www.tauns.co.jp/en

Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.

Tauns Laboratories Headlines

No Headlines